GKV Capital Management Co. Inc. Invests $154,000 in SPDR S&P Biotech ETF $XBI

GKV Capital Management Co. Inc. acquired a new position in shares of SPDR S&P Biotech ETF (NYSEARCA:XBI) in the first quarter, Holdings Channel reports. The institutional investor acquired 1,902 shares of the exchange traded fund’s stock, valued at approximately $154,000.

A number of other hedge funds also recently made changes to their positions in the stock. Bourgeon Capital Management LLC grew its stake in SPDR S&P Biotech ETF by 6.1% during the first quarter. Bourgeon Capital Management LLC now owns 2,822 shares of the exchange traded fund’s stock worth $229,000 after purchasing an additional 163 shares during the period. First Heartland Consultants Inc. grew its stake in SPDR S&P Biotech ETF by 2.7% during the first quarter. First Heartland Consultants Inc. now owns 6,344 shares of the exchange traded fund’s stock worth $514,000 after purchasing an additional 168 shares during the period. Arlington Financial Advisors LLC grew its stake in SPDR S&P Biotech ETF by 0.8% during the first quarter. Arlington Financial Advisors LLC now owns 22,685 shares of the exchange traded fund’s stock worth $1,840,000 after purchasing an additional 181 shares during the period. Institute for Wealth Management LLC. grew its stake in SPDR S&P Biotech ETF by 2.0% during the first quarter. Institute for Wealth Management LLC. now owns 9,676 shares of the exchange traded fund’s stock worth $785,000 after purchasing an additional 186 shares during the period. Finally, Private Trust Co. NA grew its stake in SPDR S&P Biotech ETF by 7.0% during the first quarter. Private Trust Co. NA now owns 2,834 shares of the exchange traded fund’s stock worth $230,000 after purchasing an additional 186 shares during the period.

SPDR S&P Biotech ETF Price Performance

NYSEARCA XBI opened at $89.85 on Friday. The business has a 50 day simple moving average of $86.84 and a 200 day simple moving average of $83.87. SPDR S&P Biotech ETF has a one year low of $66.66 and a one year high of $105.47. The stock has a market capitalization of $4.89 billion, a P/E ratio of 11.47 and a beta of 0.97.

About SPDR S&P Biotech ETF

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.